My Google Scholar
1. Prevalence of hemoglobinopathies in Sulaimani/Iraq. Sana D Jalal, Nasir Allawi, Azad H Faraj & Najmaldeen H Ahmad , DMJ 2008;2(1):71-79.
2. Beta thalassemia mutations in the Kurdish population on Northeastern Iraq. Sana D Jalal, Nasir Allaw, Nooshin Bayat, Hashem Imanian, Hossein Najmabadi & Azad Faraj. Hemoglobin 2010;34(5):469-476.
3. Prevalence & hematologic profile of delta beta thalassemia trait in Sulaimani Province /Iraq /Kurdistan. Sana D Jalal, DMJ2010;4(2):84-91.
4. Throbmocytopenia in Iraqi pregnant Women. Asmaa Thanoon& Sana D Jalal. J Fac Med 2011;53(2):171-174.
5. Prevalence and molecular characterization of G6PD deficient variants in Sulaimani Province /Iraq. Adil AZ Esssa, Fatih A Muhammad,Ali I Muhammad, Nasir AS AL Allawi, Sana D Jalal, Jaladet MS Jubrael. Duhok Med J 2012;5(2):69-75.
6. Sickle cell disease in the Kurdish population of northern Iraq.Al-Allawi NA, Jalal SD, Nerwey FF, Al-Sayan GO, Al-Zebari SS, Alshingaly AA, Markous RD, Jubrael JM, Hamamy H. Hemoglobin. 2012;36(4):333-42
7. Philadelphia-chromosome positive acute lymphoblastic leukaemia manifested as aberrant myeloid expression in a child with acute lymphoblastic leukaemia
Hassanain H. Hassan, Sana Delawar. www.BloodMed .com, edited by Barbara Bain .Case report and images.2012
8. XMN1 polymorphisim in beta thalassemic patients in the Duhok region-Iraq. Nasir Al Allawi, Farida F Neirway, Dilan Jasim, Sharaza Q Omer , Sana D Jalal , Raji D Marous. DMJ ,2012;6(1) :1-7.
9. The spectrum of alfa thalassemia mutations in the Kurdish population of Northeastern Iraq. Nasir A allaw , Sana D Jalal, Najeeb S Rasheed ,Nosheen Bayat, Hashem Imanian, Hossein Najmabadi and Azad H Faraj .Hemoglobin,2013;37(1) :56-64.
10. The Spectrum of β-thalassemia mutations in Baghdad – Central Iraq. Nasir AS Al-Allawi, Bassam MS Al-Musawi, Ameer I Ahmed, Sana D Jalal. Hemoglobin.2013;37(5):444-53.
11. The first five years of preventive programme for haemoglobinopathies in Northeastern Iraq. Nasir AS Al Allawi , Sana D Jalal, Najmaddin H Ahmed, Azad H Faraj, Awaz Shalli and Hanan Al Hamamy. J Med Screen, 2013; 20(4):171-176.
12. Beta thalassemia Intermedia in Northern Iraq: A single center experience. Nasir AS Al Allawi, Sana D Jalal, Ameen M Mahmood, Sharaza Q Omer, and Raji SD Markous. Biomed Research International, Volume 2014 (2014), Article ID 262853, 9 pages http://dx.doi.org/10.1155/2014/262853 .
13. Immunophynotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients. Int J Lab Hem 2017;1-8.
14. A case report of young female with plasma cell leukemia. Rashed NG, Jalal SD. IJH, 2017; 6:94-96.
15. Immunological profile of acute myeloid leukemia in Kurdistan Iraq. Salim AW, Jalal SD. DMJ, 2018; 12(1):1-12.
16. The incidence of thrombocytopenia among 600 pregnant ladies in Sulaimani-Iraq. Hassan NH, Shalli AA, Jalal SD and Mustafa AR. JSMC, 2017; 7(4):355-360.
17. Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age. Rafil T. Yaqo, Sana D. Jalal, MBChB2; Kharaman J. Ghafour, Hemin A. Hassan, and Michael D. Hughson. J of Global Oncology. DOI https://doi.org/10. 1200/JGO.18.00241.
18. A female with classical paroxysmalnocturnal hemoglobinuria misdiagnosed as megaloblastic anemia. Jalal SD, Saeed Sh M, Rashid NG, Saeed AS. Case report. IJH.2019; 8(2):81-83.
19. The evaluation of platelets parameters in patients with acute coronary syndrome from single cardiac center in northeastern Iraq. Abdullah KH , Shalli AAK, Muhammad AI, Jalal SD JKBMS.2021;7(2).Accepted paper.
20. Pattern, clinical and laboratory features from of adult acute lymphoblastic leukemia patients from Kurdistan-Iraq. Muhammed DJ, Jalal SD, Yassin AK, Muhammad AI .JKBMS.2021;7(2).Accepted paper.
21. Beta-Thalassemia Intermedia: A Single Thalassemia Center .Experience from Northeastern Iraq. Amin SS, Jalal SD, Ali KM, Mohammed AI, Rasool LK, Osman TJ. BioMed Research International .https://doi.org/10.1155/2020/2807120.
22. ABO Blood Groups and Thrombophilia Markers in Patients with Unstimulated Thrombosis in Kurdistan Region of Iraq. Ali Ibrahim Mohammed AI, Abdulqader AMR, Jalal SD, Mahmood SN.Clinical and Applied Thrombosis/Hemostasis; 26: 1-6.
23. The Outcome of Acute lymphoblastic leukemia in 109 Adult Iraqi Patients. Dunya J. Mohammed, Sana D. Jalal, Ahmed K. Yassin, Ali I. Mohammed Nasir A. Al-Allawi) . IJTB, (DOI: 10.1007/s12288-020-01345-1). In publication.
24. Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq. Amin SS, Jalal SD, Ali KM, Rasool LK, Osman TJ, Omed Ali, Abdullhameed M-Saeed. International Journal of General Medicine 2020:13 1453–1467.
25. Genetic epidemiology of hemoglobinopathies among Iraqi Kurds .Nasir Al-Allawi1 & Sarah Al Allawi2 & Sana D. Jalal. Journal of Community Genetics (2021) 12:5–14https://doi.org/10.1007/s12687-020-00495-z.
26. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories. Sana Dlawar Jalal .PLoS ONE 16(2): e0247491. https://doi.org/10.1371/journal.pone.0247491.
27-The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Maysam Basim Najm, Sana Dlawar Jalal, Hisham Arif Getta. Cellular and molecular biology (2022),68(8);202-209.https://doi.org/10.14715/cmb/2022.68.8.34%20%20%20